HRMY ▼ -5.8% - Harmony Biosciences Holdings, Inc. $HRMY reported Q3 2026 EPS of $0.81, missing the $1.37 estimate by 40.9%. Revenue of $268.9M missed the $271.8M estimate by 1.1% 04-NOV-2026 07:38 AM ET